Patient Advocates With Multiple Sclerosis Fund Clinical Trial Of Promising Drug That Has Already Helped Thousands

... Over the last decade, anecdotal reports suggested that a very low dose of an FDA-approved drug called naltrexone provides effective symptom relief for many patients who suffer from Multiple Sclerosis. Frustrated by the lack of scientific research, volunteers began raising money to fund a human clinical trial of Low Dose Naltrexone (LDN) for MS. [click link for full article] ...